Has Richard Vowles received payments from drug or device companies?

Yes. Drug and device makers reported $10,445 in general payments to Richard Vowles across 368 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Vowles did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Vowles come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Vowles

Psychiatric/Mental Health · Yulee, FLNPI 1619631124

Payments from drug & device makers

$10,445in general payments, 2019–2025

Across 368 payments — averaging $28.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$4K
Teva Pharmaceuticals USA, Inc.$2K
AbbVie$993
Alkermes, Inc.$805
Johnson & Johnson$693
Takeda Pharmaceuticals U.S.A., Inc.$378
plus $2K from 9 others

What the payments were for

Consulting fees$1,60015%
Travel & lodging$7157%
Food & beverage$8,05377%
Education$771%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	57	$4,073
Teva Pharmaceuticals USA, Inc.	91	$1,887
AbbVie	60	$993
Alkermes, Inc.	35	$805
Johnson & Johnson(2 entities)	30	$693
Takeda Pharmaceuticals U.S.A., Inc.	19	$378
Axsome Therapeutics, Inc.	9	$356
Otsuka America Pharmaceutical, Inc.	16	$350
Vanda Pharmaceuticals Inc.	18	$322
Neurocrine Biosciences, Inc.	15	$258
Indivior Inc.	8	$147
Lundbeck LLC	3	$58
E.r. Squibb & Sons, L.L.C.	2	$48
Sunovion Pharmaceuticals Inc.	3	$39
Noven Therapeutics, LLC	2	$37

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,445 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Austedo XrDeutetrabenazine	16	$194,409
CaplytaLumateperone Tosylate	32	$71,221
LybalviOlanzapine/Samidorphan Malate	24	$37,483
VraylarCariprazine Hcl	11	$22,784
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	37	$1,831
Hydroxyzine Hcl	22	$878
Quetiapine Fumarate	26	$861
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	14	$758
Ziprasidone Hcl	12	$550
Trazodone Hcl	23	$549
Gabapentin	24	$375
Venlafaxine Hcl ErVenlafaxine Hcl	14	$201
Duloxetine Hcl	12	$136
Escitalopram Oxalate	13	$113
Clonidine Hcl	32	$97

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr	$1,887	$194,40916 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$4,073	$71,22132 claims
Alkermes, Inc.Lybalvi	$805	$37,48324 claims
AbbVieVraylar	$993	$22,78411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Yulee

Roger RiveraKissimmee$1.6M
Bethanie Simmons BecilJacksonville$782K
Hannah PhillipsMaitland$455K
Cheedy JajaTampa$266K
Scott DurrancePensacola$224K
Eudaldo AponteHialeah$214K
Heather WarrenTallahassee$172K
Angela DavenportAlachua$83K
Natalie MoodyWinter Haven$75K
Kelli BridgmanNew Smyrna Beach$66K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →